## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `retatrutide-tirzepatide`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/retatrutide-tirzepatide/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/retatrutide-tirzepatide/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/retatrutide-tirzepatide/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/retatrutide-tirzepatide/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/retatrutide-tirzepatide/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/retatrutide-tirzepatide/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `retatrutide-tirzepatide` v2 · content_hash `ef2fff5229450354…` · thread_head genesis · 21 DIVs
- **thesis (c1):** Retatrutide 12 mg produced mean 24.2% weight loss at 48 weeks in phase 2 obesity trial versus 2.1% placebo.
  - c2 [human/active] Tirzepatide 15 mg produced mean 20.9% weight loss at 72 weeks in SURMOUNT-1 versus 3.1% placebo.
  - c3 [mechanistic/active] Each additional pound of body weight adds approximately 4 lb compressive force to the lumbar spine during walking.
  - c4 [anecdotal/active] Reddit users report personal weight losses of 50-100 lb on these compounds with variable appetite effects between them.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/retatrutide-tirzepatide/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/retatrutide-tirzepatide/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `retatrutide-tirzepatide`
- **title:** Retatrutide vs Tirzepatide: Human Trial Data on Weight Loss and Load Reduction
- **url:** https://miscsubjects.com/a/retatrutide-tirzepatide
- **register:** source_ledger
- **updated:** 2026-07-17T02:41:22.042Z
- **tags:** peptide, matrix

## Body

## What's breaking down

Excess body weight increases compressive forces across the spine, hips, knees and feet. Each extra pound of body mass adds roughly 4 pounds of load to the lumbar spine during walking. When body weight stays elevated, mechanical stress outpaces natural repair in load-bearing tissues. Both compounds are studied for effects on body weight through GLP-1 and related pathways; any benefit to joints or spine would come from reduced load rather than direct tissue regeneration.

## Why Retatrutide might help you

1. What keeps failing: Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.
2. What Retatrutide is studied to do: Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.
3. Therefore for you: If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.

## Why Tirzepatide might help you

1. What keeps failing: Same mechanical overload pattern as other GLP-1 contexts at higher body weight.
2. What Tirzepatide is studied to do: Studied for GLP-1/GIP weight loss — load reduction on spine and joints.
3. Therefore for you: If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.

## How these fit together

Each compound above targets a different degeneration layer. Together they are a stack — not five copies of the same mechanism.
- Retatrutide → metabolic load / body weight
- Tirzepatide → metabolic load / body weight

## What the evidence actually shows

Human phase 2 and phase 3 trials (human tier) show both compounds produce substantial weight loss. In one retatrutide trial, the 12 mg dose produced mean weight loss of 24.2% at 48 weeks versus 2.1% on placebo. In the SURMOUNT-1 tirzepatide trial, 15 mg produced mean weight loss of 20.9% at 72 weeks versus 3.1% on placebo. Later retatrutide phase 3 data (TRIUMPH-1) reported 28.3% mean loss at 80 weeks on 12 mg. These are percentage changes from baseline body weight in adults with obesity or overweight; results are dose-dependent and gastrointestinal side effects were common during escalation. No head-to-head trials exist yet. All data are from randomized controlled trials published in NEJM and company reports.

## What scientists say

Published trial authors note the weight reductions exceed those seen with earlier GLP-1 agents and approach levels associated with bariatric surgery in some participants. Reductions in waist circumference, blood pressure and lipids were also observed alongside weight change. Researchers emphasize these are short-to-medium term findings (up to 104 weeks in extensions) and longer-term maintenance and safety data are still being collected.

## What people say on Reddit

Anecdotal reports (anecdotal tier) describe users switching between the two, with some noting stronger appetite suppression on tirzepatide and others preferring retatrutide for perceived energy or easier protein intake. Individual losses of 50–100 lb are mentioned after months of use, but experiences vary widely and many discuss side effects or dose titration challenges. These are self-reported posts from r/RetatrutideTrial, r/Mounjaro and similar communities.

## What people say on X

Public posts on X are limited in the searched results; available mentions largely repeat trial headlines or user interest in upcoming approvals rather than detailed personal outcomes.

## What we do not know

Direct comparative efficacy, long-term joint or spine outcomes, effects on specific degenerative conditions, and durability of weight loss after discontinuation remain unknown. No human data link either compound to direct cartilage or disc repair independent of weight change.

## Safety and limits

Both compounds show gastrointestinal adverse events that are mostly mild to moderate and dose-related in trials. Heart rate increases were noted with retatrutide. These remain investigational or approved agents with specific indications; individual responses differ and monitoring by a clinician is required in any real-world use.

## Claims (4)

- **c3** [mechanistic w=0.3] Each additional pound of body weight adds approximately 4 lb compressive force to the lumbar spine during walking.
  - who_claims: grok/grok-4.3
- **c1** [human w=0.8] Retatrutide 12 mg produced mean 24.2% weight loss at 48 weeks in phase 2 obesity trial versus 2.1% placebo.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c2** [human w=0.8] Tirzepatide 15 mg produced mean 20.9% weight loss at 72 weeks in SURMOUNT-1 versus 3.1% placebo.
  - who_claims: grok/grok-4.3
  - sources: s2
- **c4** [anecdotal w=0.3] Reddit users report personal weight losses of 50-100 lb on these compounds with variable appetite effects between them.
  - who_claims: grok/grok-4.3
  - sources: s3

## Voxel graph (4 atoms · 7 edges)
- full graph: https://miscsubjects.com/api/articles/retatrutide-tirzepatide/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (3)
- chain valid: yes · head: `b39e9694908231f8`

### s1 · pubmed · http_403
- title: Triple–Hormone-Receptor Agonist Retatrutide for Obesity
- url: https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
- summary: Phase 2 trial results for retatrutide weight loss.
- quote: At 48 weeks, the least-squares mean percentage change in the retatrutide groups was −8.7% in the 1-mg group, −17.1% in the combined 4-mg group, −22.8% in the combined 8-mg group, and −24.2% in the 12-mg group, as compared with −2.1% in the placebo group.
- claim_ids: c1
- hash: `6a1e25314940e559`

### s2 · pubmed · http_403
- title: Tirzepatide Once Weekly for the Treatment of Obesity
- url: https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
- summary: SURMOUNT-1 tirzepatide weight loss data.
- quote: the mean percentage change in weight at week 72 was −15.0% ... −19.5% ... and −20.9% ... and −3.1% ... with placebo
- claim_ids: c2
- hash: `b3088396a6ca6210`

### s3 · reddit · ok
- title: Tirzepatide or Retatrutide??
- url: https://www.reddit.com/r/RetatrutideTrial/comments/1nwzgnd/tirzepatide_or_retatrutide/
- summary: User anecdotes on switching and losses.
- quote: I lost 100 pounds with tirzepetide and am now maintaining with reta.
- claim_ids: c4
- hash: `b39e9694908231f8`

## Provenance (2 model passes)
- chain valid: yes · head: `5504295112672348`

- write · grok/grok-4.3 · 2026-06-30T00:50 · hash `dcd5b77ea49b`
- voxel_divide · owner · 2026-07-17T02:41 · hash `550429511267`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/retatrutide-tirzepatide/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/retatrutide-tirzepatide/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"retatrutide-tirzepatide","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest retatrutide-tirzepatide|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim retatrutide-tirzepatide|tier|assertion`
- **iMessage ask:** `retatrutide-tirzepatide|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `retatrutide-tirzepatide`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/retatrutide-tirzepatide/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/retatrutide-tirzepatide/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*